Mier W - Search Results

1

Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.

Slijepcevic D, Kaufman C, Wichers CG, Gilglioni EH, Lempp FA, Duijst S, de Waart DR, Elferink RP, Mier W, Stieger B, Beuers U, Urban S, van de Graaf SF. Slijepcevic D, et al. Among authors: mier w. Hepatology. 2015 Jul;62(1):207-19. doi: 10.1002/hep.27694. Epub 2015 May 8. Hepatology. 2015. PMID: 25641256 Free PMC article.

2

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

Petersen J, Dandri M, Mier W, Lütgehetmann M, Volz T, von Weizsäcker F, Haberkorn U, Fischer L, Pollok JM, Erbes B, Seitz S, Urban S. Petersen J, et al. Among authors: mier w. Nat Biotechnol. 2008 Mar;26(3):335-41. doi: 10.1038/nbt1389. Epub 2008 Feb 24. Nat Biotechnol. 2008. PMID: 18297057

3

Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Schulze A, Schieck A, Ni Y, Mier W, Urban S. Schulze A, et al. Among authors: mier w. J Virol. 2010 Feb;84(4):1989-2000. doi: 10.1128/JVI.01902-09. Epub 2009 Dec 9. J Virol. 2010. PMID: 20007265 Free PMC article.

4

Solid-phase synthesis of the lipopeptide Myr-HBVpreS/2-78, a hepatitis B virus entry inhibitor.

Schieck A, Müller T, Schulze A, Haberkorn U, Urban S, Mier W. Schieck A, et al. Among authors: mier w. Molecules. 2010 Jul 7;15(7):4773-83. doi: 10.3390/molecules15074773. Molecules. 2010. PMID: 20657392 Free PMC article.

5

Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes.

Meier A, Mehrle S, Weiss TS, Mier W, Urban S. Meier A, et al. Among authors: mier w. Hepatology. 2013 Jul;58(1):31-42. doi: 10.1002/hep.26181. Epub 2013 Mar 14. Hepatology. 2013. PMID: 23213046

6

Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts.

Schieck A, Schulze A, Gähler C, Müller T, Haberkorn U, Alexandrov A, Urban S, Mier W. Schieck A, et al. Among authors: mier w. Hepatology. 2013 Jul;58(1):43-53. doi: 10.1002/hep.26211. Epub 2013 May 15. Hepatology. 2013. PMID: 23292963

7

Liver imaging with a novel hepatitis B surface protein derived SPECT-tracer.

Müller T, Mehrle S, Schieck A, Haberkorn U, Urban S, Mier W. Müller T, et al. Among authors: mier w. Mol Pharm. 2013 Jun 3;10(6):2230-6. doi: 10.1021/mp400038r. Epub 2013 May 3. Mol Pharm. 2013. PMID: 23601010

8

Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

Nkongolo S, Ni Y, Lempp FA, Kaufman C, Lindner T, Esser-Nobis K, Lohmann V, Mier W, Mehrle S, Urban S. Nkongolo S, et al. Among authors: mier w. J Hepatol. 2014 Apr;60(4):723-31. doi: 10.1016/j.jhep.2013.11.022. Epub 2013 Dec 1. J Hepatol. 2014. PMID: 24295872

9

Renal Targeting: Peptide-Based Drug Delivery to Proximal Tubule Cells.

Wischnjow A, Sarko D, Janzer M, Kaufman C, Beijer B, Brings S, Haberkorn U, Larbig G, Kübelbeck A, Mier W. Wischnjow A, et al. Among authors: mier w. Bioconjug Chem. 2016 Apr 20;27(4):1050-7. doi: 10.1021/acs.bioconjchem.6b00057. Epub 2016 Mar 30. Bioconjug Chem. 2016. PMID: 26999755

10

A liposomal formulation for the oral application of the investigational hepatitis B drug Myrcludex B.

Uhl P, Helm F, Hofhaus G, Brings S, Kaufman C, Leotta K, Urban S, Haberkorn U, Mier W, Fricker G. Uhl P, et al. Among authors: mier w. Eur J Pharm Biopharm. 2016 Jun;103:159-166. doi: 10.1016/j.ejpb.2016.03.031. Epub 2016 Apr 2. Eur J Pharm Biopharm. 2016. PMID: 27049970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters